Skip to content

Author

Qamar Abuhassan

We have 6 of 98 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Aug 2026

Viral modulation of angiogenesis through microRNA networks: Implications for cancer biology, biomarkers, and therapy.

Angiogenesis is essential for development, tissue repair, and vascular homeostasis, whereas dysregulated neovascularization contributes to chronic inflammation, ischemic injury, and cancer progression. Viral infections can reshape vascular programs through endothelial signaling, immune responses, metabolic stress, and...

Qamar Abuhassan, Waleed K. Abdulsahib, Sanan Thaer Abdalwahab et al. · 0 citations
Review Open access Aug 2026

RNA vaccines in motion: A multidisciplinary exploration of design, delivery, and deployment

Overall, continued refinement of RNA sequence engineering and delivery systems positions these platforms as flexible tools for rapid-response vaccination and therapy, especially where fast antigen adaptation and scalable production are required.

Qamar Abuhassan, Ahmed Aldulaimi, O. Waleed et al. · 0 citations
Review Sep 2026

Nanotheranostics in orthopedic diseases: a critical review of molecular diagnostic-driven targeted therapeutics for personalized patient care.

INTRODUCTION Orthopedics could greatly benefit from nanotechnology, especially in drug delivery, bone tissue engineering, and implant design. Nanotheranostics represents a major step toward individualized treatment by combining diagnosis and treatment into a single nanoplatform. For orthopedic applications, nanocarrier...

Qamar Abuhassan, Husni Farah, M. Rekha et al. · 0 citations
Review Open access Sep 2026

Targeting the Immunosuppressive Microenvironment in Colorectal Cancer: Pharmacological and Nanomedicine Strategies

The fundamental immunosuppressive interactions within the TME are discussed and subsequently it is examined how these agents enhance immune responses by reprogramming stromal and immune cells, as well as their secreted mediators within the TIME.

Qamar Abuhassan, Usamah Sayed, Pareshkumar N. Patel et al. · 0 citations
Review Sep 2026

Pyroptosis in Triple-Negative Breast Cancer: From Inflammasome Signaling to Tumor Immune Remodeling and Translational Therapeutic Strategies.

This review critically examines pyroptosis-TIME crosstalk in TNBC, prioritizing TNBC and breast cancer evidence while using non-breast cancer findings only as mechanistic comparators when they clarify conserved inflammasome or gasdermin biology.

Qamar Abuhassan, M. Al-Khreisat, R. Roopashree et al. · 1 citation
Review Sep 2026

Phage-based biosensors for Cancer biomarker detection and diagnosis.

Phage-based biosensors have great potential for use in the early identification of disease, which would provide viable alternatives to liquid biopsy as well as point-of-care testing techniques for early identification of cancers.

Qamar Abuhassan, G. Oriquat, Subbulakshmi Ganesan et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.